It showed that the STAT3 score, nuclear STAT3 score, pathological stage (≥ pT3), lymph node involvement, lymphovascular invasion, and tumor grade were associated with both progression-free survival (Table 2) and cancer-specific survival (Table 3). This evidence concerns the gene STAT3 and cancer.